Prévalence des effets indésirables de l’hydroxychloroquine (Plaquenil®) dans une population dermatologique : étude rétrospective sur 102 patients
Sign Up to like & getrecommendations! Published in 2018 at "Annales De Dermatologie Et De Venereologie"
DOI: 10.1016/j.annder.2018.03.168
Abstract: Resume But L’objectif de cette etude etait d’etudier la prevalence des effets indesirables (EI) et celle de l’arret de l’hydroxychloroquine (HCQ) pour EI dans une population issue d’un recrutement dermatologique. Patients et methodes Il s’agissait… read more here.
Keywords: des effets; hcq; une population; 102 patients ... See more keywords
FRI0504 Diffuse alveolar haemorrhagein anca-associated vasculitis: can we predict outcome? an italian multicentre retrospective long-term study of 102 patients
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.4196
Abstract: Background Diffuse alveolar haemorrhage (DAH) is a rare and severe manifestation of ANCA-associated vasculitides (AAV). Objectives To identify predictors of survival in patients with AAV-DAH. Methods A retrospective study of 102 consecutive patients (50% females;… read more here.
Keywords: diffuse alveolar; 102 patients; anca associated; study 102 ... See more keywords
A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer (HGCSG1503): Analysis of cases of prior regorafenib.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.832
Abstract: 832Background: The J003 trial and RECOURSE trial revealed the safety and efficacy of TAS-102 for patients with metastatic colorectal cancer (mCRC). In March 2014, TAS-102 was approved in Japan. How... read more here.
Keywords: metastatic colorectal; safety efficacy; 102 patients; patients metastatic ... See more keywords
Factors associated with efficacy of TAS-102 in patients with refractory metastatic colorectal cancer (mCRC).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.858
Abstract: 858Background: TAS-102 significantly improved progression free survival (PFS) and overall survival (OS) versus placebo in patients with treatment refractory mCRC. We analyzed potential predictive and prognostic factors in patients treated with TAS-102 in real-world practice.… read more here.
Keywords: mcrc; 102 patients; efficacy tas; factors associated ... See more keywords
[Therapeutic plasma exchange. Experience in 102 patients].
Sign Up to like & getrecommendations! Published in 2022 at "Revista medica de Chile"
DOI: 10.4067/s0034-98872022000200147
Abstract: BACKGROUND Therapeutic Plasma Exchange (TPE) is a procedure in which plasma and harmful macromolecules are separated from the rest of the blood components by centrifugation or filtration through membranes and are replaced with solutions with… read more here.
Keywords: therapeutic plasma; plasma exchange; experience; 102 patients ... See more keywords